GL1X · GenesisL1 explorer

MolNFT v1 · #41028 · protein

Crystal structure of the mutant H573A of the nuclease domain of COLE7 in complex with IM7

2JB0 · Colicin E7 immunity protein: “Crystal structure of the mutant H573A of the nuclease domain of COLE7 in complex with IM7”. X-ray diffraction, 1 ligand (ZN), 3 pockets (best druggability 0.46). MolNFT v1 #41028 on GenesisL1: 3D…

PDB
2JB0
Type
protein
Length
206 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Colicin E7 immunity protein; Colicin E7
EC
3.1.-.-
UniProt
Q03708, Q47112
Ligands
ZN
Pockets
3 · best druggability 0.46

Structure

x-ray diffraction · 2 distinct chains · 48% helix, 11% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AColicin E7 immunity protein (EC 3.1.-.-)protein8460% helix, 0% strandQ03708
BColicin E7 (EC 3.1.-.-)protein12240% helix, 18% strandQ47112

Ligands and binding sites

  • ZN · Zinc ion · metal · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11440.460.7722empty
2820.370.7713empty
3810.290.7219empty

Interfaces

1 interface between chains.

  • A–B · 749 Ų buried · 15 hydrogen bonds · protein-protein

Compared structures

  • 2JB0 · Crystal structure of the mutant H573A of the nuclease domain of COLE7 in complex with IM7 · the same entry in another collection · chain B against B, TM-score 1.00
  • Q03708 · AlphaFold monomer V2.0 prediction for colicin-E7 immunity protein (Q03708) · a predicted model of the same protein · chain A against A, TM-score 0.99
  • Q47112 · AlphaFold monomer V2.0 prediction for colicin-E7 (Q47112) · a predicted model of the same protein · chain B against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.